PDCD1 and intrahepatic cholangiocarcinoma: In present studies, 233 (72.8%) ICC patients had HBV infection, and the number of PD1+ T cells in the tumor tissues from ICC patients only with HBV infection was significantly more than those from patients with hepatolithiasis and those from patients with undefined risk factor.